Literature DB >> 10418884

Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment.

T I Hillen1, S L Grbavac, P J Johnston, J A Straton, J M Keogh.   

Abstract

PURPOSE: To explore the prevalence of dysmenorrhea among senior high school girls in Perth, Western Australia, its impact on school, sporting, and social activities, students' management strategies, and their knowledge of available treatment.
METHODS: A total of 388 female students in Grades 11 and 12 at three metropolitan secondary schools completed an anonymous questionnaire administered during class time. The following definition of dysmenorrhoea was used: any type of pain or discomfort associated with menstrual periods including cramps, nausea, and headaches.
RESULTS: The reported prevalence of dysmenorrhea among these girls was 80%; 53% of those girls with dysmenorrhea reported that it limited their activities. In particular, 37% said that dysmenorrhea affected their school activities. The most common medication used by those reporting dysmenorrhea was simple analgesics (53%), followed by nonsteroidal anti-inflammatory drugs (NSAIDs), used by 42%. More than a quarter of respondents (27%) were unaware that NSAIDs were a possible treatment option for dysmenorrhea.
CONCLUSION: The prevalence and impact of dysmenorrhea on Grade 11 and 12 girls is high, and they lack knowledge of and experience with effective treatment. Health education measures are needed in this area to prevent unnecessary suffering and interruption to school routine.

Entities:  

Mesh:

Year:  1999        PMID: 10418884     DOI: 10.1016/s1054-139x(98)00147-5

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  53 in total

1.  Developmental associations between adolescent change in depressive symptoms and menstrual-cycle-phase-specific negative affect during early adulthood.

Authors:  Jeff Kiesner; François Poulin
Journal:  J Youth Adolesc       Date:  2011-10-16

2.  Menstrual-related attitudes and symptoms among multi-racial Asian adolescent females.

Authors:  Li Ping Wong; Ee Ming Khoo
Journal:  Int J Behav Med       Date:  2010-05-04

3.  Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents.

Authors:  Hasan H Özdemir; Sefer Varol; Eşref Akıl; Abdullah Acar; Caner F Demir
Journal:  Neurol Sci       Date:  2014-08-05       Impact factor: 3.307

Review 4.  A contemporary approach to dysmenorrhea in adolescents.

Authors:  Zeev Harel
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Factors related to dysmenorrhea among Vietnamese and Vietnamese marriage immigrant women in South Korea.

Authors:  In Ae Jang; Min Yeoung Kim; Sa Ra Lee; Kyung Ah Jeong; Hye Won Chung
Journal:  Obstet Gynecol Sci       Date:  2013-07-15

6.  Menstrual symptoms in adolescent girls: association with smoking, depressive symptoms, and anxiety.

Authors:  Lorah D Dorn; Sonya Negriff; Bin Huang; Stephanie Pabst; Jennifer Hillman; Paula Braverman; Elizabeth J Susman
Journal:  J Adolesc Health       Date:  2008-10-29       Impact factor: 5.012

7.  The measurement of menstrual symptoms: factor structure of the menstrual symptom questionnaire in adolescent girls.

Authors:  Sonya Negriff; Lorah D Dorn; Jennifer B Hillman; Bin Huang
Journal:  J Health Psychol       Date:  2009-10

Review 8.  Exercise and primary dysmenorrhoea : a comprehensive and critical review of the literature.

Authors:  Amanda J Daley
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

9.  Pain Catastrophizing Predicts Menstrual Pain Ratings in Adolescent Girls with Chronic Pain.

Authors:  Laura A Payne; Andrea J Rapkin; Kirsten C Lung; Laura C Seidman; Lonnie K Zeltzer; Jennie C I Tsao
Journal:  Pain Med       Date:  2016-01       Impact factor: 3.750

Review 10.  Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.

Authors:  Jane Marjoribanks; Reuben Olugbenga Ayeleke; Cindy Farquhar; Michelle Proctor
Journal:  Cochrane Database Syst Rev       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.